Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A call to action

J Shepherd1

  • 1Department of Pathological Biochemistry, Glasgow Royal Infirmary, Scotland, U.K.

European Heart Journal
|November 20, 1998
PubMed
Summary
This summary is machine-generated.

Acute myocardial infarction (AMI) is a leading cause of death. Implementing lifestyle changes and managing blood pressure and lipid profiles can reduce cardiovascular risk, but physician adoption of guidelines remains slow.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the knowledge base of ChatGPT in lateral elbow tendinopathy.

Shoulder & elbow·2026
Same author

Statistical shape modelling of the first carpometacarpal joint: A cross-sectional analysis of an osteoarthritis initiative cohort.

Bone·2025
Same author

How do digital range of motion measurement devices 'measure-up' to traditional goniometry in assessing shoulder range of motion? A systematic review and meta-analysis.

Shoulder & elbow·2024
Same author

The economic and resource burden of e-scooter-related orthopaedic injuries: A district general hospital's experience.

Injury·2024
Same author

Development of a novel micro-bead force spectroscopy approach to measure the ability of a thermo-active polymer to remove bacteria from a corneal model.

Scientific reports·2021
Same author

Risk factors for preeclampsia and eclampsia at a main referral maternity hospital in Freetown, Sierra Leone: a case-control study.

BMC pregnancy and childbirth·2021
Same journal

The surgical collateralization theory: has the beautiful hypothesis been killed by the ugly facts?

European heart journal·2026
Same journal

Beyond single measurement: additional considerations for high-sensitivity C-reactive protein in cardiovascular risk prediction.

European heart journal·2026
Same journal

Brain mineralocorticoid receptor activation and antagonism in heart failure with preserved ejection fraction: a hypothesis.

European heart journal·2026
Same journal

Myths and misconceptions about high-sensitivity C-reactive protein as a marker of residual inflammatory risk.

European heart journal·2026
Same journal

Vascular Ehlers-Danlos syndrome: should we treat asymptomatic patients?

European heart journal·2026
Same journal

Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease.

European heart journal·2026
See all related articles

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Public Health

Background:

  • Acute myocardial infarction (AMI) remains a primary cause of mortality in individuals over 40.
  • Despite observed reductions in coronary heart disease (CHD) mortality, significant potential exists for further decrease.
  • Cardiovascular morbidity and mortality can be reduced through lifestyle interventions and control of hypertension and dyslipidemia.

Purpose of the Study:

  • To emphasize the need for multifactorial approaches in cardiovascular disease (CVD) prevention.
  • To highlight the gap between established clinical guidelines and their implementation by physicians.
  • To advocate for the integration of lipid-lowering therapy in CHD prevention strategies.

Main Methods:

  • Review of existing guidelines for primary and secondary CHD prevention.

Related Experiment Videos

  • Analysis of survey data on physician practices regarding risk factor management.
  • Emphasis on the role of lifestyle interventions, blood pressure control, and lipid management.

    • Main Results:

    • Physicians have been slow to adopt and implement CHD prevention guidelines.
    • Routine measurement of serum cholesterol concentrations is inadequate.
    • Hypercholesterolemia is frequently undertreated, despite the availability of effective lipid-lowering agents.

    Conclusions:

    • A multifactorial approach is essential for effective CVD risk reduction.
    • Physicians must improve adherence to clinical guidelines for CHD prevention.
    • Lipid-lowering therapy should be considered a cornerstone of both primary and secondary CHD prevention.